SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Nanavaty Maulik

(Last)

(First)

(Middle)

ONE BOSTON SCIENTIFIC PLACE

(Street)

NATICK

01760-1537

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/06/2011

3. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP & President, Neuromodula

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	45,336⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Deferred Stock Units	⁽²⁾	02/12/2018	Common Stock	10,784⁽³⁾	$0.0000⁽⁴⁾	D
Deferred Stock Units	⁽⁵⁾	02/13/2017	Common Stock	1,638⁽⁶⁾	$0.0000⁽⁴⁾	D
Deferred Stock Units	⁽⁷⁾	02/16/2020	Common Stock	8,461⁽⁸⁾	$0.0000⁽⁴⁾	D
Deferred Stock Units	⁽⁹⁾	02/24/2019	Common Stock	6,324⁽¹⁰⁾	$0.0000⁽⁴⁾	D
Deferred Stock Units	⁽¹¹⁾	02/28/2021	Common Stock	11,348	$0.0000⁽⁴⁾	D
Deferred Stock Units	⁽¹²⁾	10/30/2017	Common Stock	9,160⁽¹³⁾	$0.0000⁽⁴⁾	D
Stock Option (Right to Buy)	⁽¹⁴⁾	02/28/2021	Common Stock	50,466	$7.16	D
Stock Option (Right to Buy)	⁽¹⁵⁾	02/16/2020	Common Stock	48,231	$7.41	D
Stock Option (Right to Buy)	⁽¹⁶⁾	02/24/2019	Common Stock	23,458	$8.3	D
Stock Option (Right to Buy)	⁽¹⁷⁾	02/12/2018	Common Stock	25,568	$12.52	D
Stock Option (Right to Buy)	⁽¹⁸⁾	09/07/2015	Common Stock	12,500	$24.26	D
Stock Option (Right to Buy)	⁽¹⁹⁾	01/03/2016	Common Stock	9,820	$24.46	D

Explanation of Responses:

1. Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

2. The award vests in five equal installments beginning on February 12, 2009, the first anniversary of the date of grant.

3. This amount represents the unvested portion of DSUs awarded on February 12, 2008 which will continue to vest in two installments on the anniversary of the grant date.

4. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

5. The award vests in five equal installments beginning on February 13, 2008, the first anniversary of the date of grant.

6. This amount represents the unvested portion of DSUs awarded on February 13, 2007 which will continue to vest in one installment on the anniversary of the grant date.

7. The award vests in five equal installments beginning on February 16, 2011, the first anniversary of the date of grant.

8. This amount represents the unvested portion of DSUs awarded on February 16, 2010 which will continue to vest in four installments on the anniversary of the grant date.

9. The award vests in five equal installments beginning on February 24, 2010, the first anniversary of the date of grant.

10. This amount represents the unvested portion of DSUs awarded on February 24, 2009 which will continue to vest in three installments on the anniversary of the grant date.

11. The award vests in five equal installments beginning on February 28, 2012, the first anniversary of the date of grant.

12. The award vests in five equal installments beginning on October 30, 2008, the first anniversary of the date of grant.

13. This amount represents the unvested portion of DSUs awarded on October 30, 2007 which will continue to vest in two installments on the anniversary of the grant date.

14. Grant to the reporting person of an option to purchase 50,466 shares of common stock vesting in four annual increments beginning on February 28, 2012, the first anniversary of the grant.

15. Grant to the reporting person of an option to purchase 48,231 shares of common stock vesting in four annual increments beginning on February 16, 2011, the first anniversary of the grant.

16. Grant to the reporting person of an option to purchase 23,458 shares of common stock vesting in four annual increments beginning on February 24, 2010, the first anniversary of the grant.

17. Grant to the reporting person of an option to purchase 25,568 shares of common stock vesting in four annual increments beginning on February 12, 2009, the first anniversary of the grant.

18. Grant to the reporting person on September 7, 2005, of an option to purchase 12,500 shares of common stock. The grant is fully vested.

19. Grant to the reporting person on January 3, 2006, of an option to purchase 9,820 shares of common stock. The grant is fully vested.

	/s/ Theresa R. Boni, Attorney-in-Fact	09/16/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.